CDK4/RB/E2Fs axis as potential therapeutic target of endometrial cancer
Open Access
- 1 May 2020
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 125, 109870
Abstract
No abstract availableKeywords
Funding Information
- Shanghai Municipal Hospital Development Center (SHDC12019113)
- National Natural Science Foundation of China (11602295)
- Science and Technology Commission of Shanghai Municipality (17ZR1421900)
This publication has 46 references indexed in Scilit:
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortalScience Signaling, 2013
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Cyclin D as a therapeutic target in cancerNature Reviews Cancer, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Emerging roles of E2Fs in cancer: an exit from cell cycle controlNature Reviews Cancer, 2009
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1Nature, 2009
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005